abstract |
The invention is directed to and certain MEK inhibitors used in the treatment of hyperproliferative diseases, such as cancer in mammals. This invention also relates to a process of using such compounds in the treatment of hyperproliferative diseases in mammals, especially humans, and for pharmaceutical compositions containing such compounds. |